- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT04504019
Resultados clínicos de USCTR vs. mOCTR
Resultados clínicos da liberação do túnel do carpo com e sem orientação por ultrassom
Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy and affects 3-6% of adults in the United States. In patients with severe or refractory symptoms, carpal tunnel release (CTR) represents the definitive management option, and over 550,000 CTRs are performed annually in the United States with over 90% of patients reporting clinical improvement. Currently available CTR techniques include mini-open CTR via a single, 1-3 cm palmar incision (mOCTR), endoscopic CTR via one (wrist) or two (wrist and palm) 1-2 cm incisions (ECTR), and ultrasound guided CTR via a single < 1 cm wrist or palmar incision (USCTR or CTR-US). The primary objective is to assess the impact of USCTR vs mOCTR in a military population. Investigators hypothesize that USCTR using the SX-One MicroKnife, also known as UltraGuideCTR, will safely and non-inferiorly improve symptoms of carpal tunnel syndrome compared to traditional mOCTR, without greater less loss of military duty days. This study is a single-site randomized controlled trial.
Participants with CTS will be randomized to a study arm and receive treatment with USCTR vs. traditional mOCTR. All patients will be followed for a period of 24 months with respect to standard clinical data, military relevant data, and validated patient related outcome measures (PROMs). Data will be collected at 1 week, 2 weeks, 3 weeks, 1 month, 6 weeks, 3 months, 6 months, and 12 months, and 24 months post-CTR procedure, with the primary focus being on outcomes up to 1 year.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Clinical outcomes of up to 83 participants (updated target sample size) treated with USCTR vs. traditional mOCTR will be investigated.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Maryland
-
Bethesda, Maryland, Estados Unidos, 20814
- Walter Reed National Military Medical Center
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Adults age ≥18 years
- DEERS Eligible
- Fluent in speaking, reading, and understanding English
- Clinical diagnosis of Carpal Tunnel Syndrome (CTS)
- Candidate for surgical CTR based on severe and/or refractory symptoms
- Confirmatory electrodiagnostic test indicating median neuropathy at the wrist (abnormal findings)
- Ultrasound findings consistent with median nerve enlargement in the carpal tunnel
Exclusion Criteria:
- Previous carpal tunnel release or previous wrist surgery on the ipsilateral side
- Carpal tunnel injection with corticosteroid within 6 weeks prior to anticipated study procedure
- Previous traumatic injury to the median nerve or any of its branches on the ipsilateral side
- History of medical condition that would preclude safe participation in study procedures (e. g. complex regional pain syndrome (CRPS), upper limb vascular disease (including thoracic outlet syndrome), Raynaud's phenomenon, etc.)
- Inability to stop anticoagulation medications (Plavix, Coumadin/Warfarin, Xarelto), or unable to be bridged with Lovenox
- Unable to understand and provide written informed consent
- Contraindication to proceeding with USCTR based on diagnostic ultrasound (i.e. identification of anomalous anatomic structures such as transligamentous thenar motor branch or space occupying lesions within the carpal tunnel)
- Electrodiagnostic evaluation of the carpal tunnel which indicates normal findings
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: USCTR Procedure
Participants will undergo the USCTR procedure with SX-One MicroKnife®, also known as UltraGuideCTR |
Ultrasound guided CTR via a single < 1 cm wrist or palmar incision. The procedure will be performed using the SX-One MicroKnife®, also known as UltraGuideCTR |
|
Comparador Ativo: mOCTR Procedure
Participants will undergo the traditional mOCTR procedure. |
Mini-open CTR via a single 1-3cm palmar incision |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Measure the Effect of USCTR vs mOCTR on the Longitudinal Change in QuickDASH.
Prazo: Change from baseline to 1 week, 2 weeks, 3 weeks, 1 month, 6 weeks, 3 months, 6 months, 12 months, and 24 months post CTR procedure were assessed. Change from baseline to 1 month, 1 year and 2 years were reported.
|
QuickDash is a region-specific PROM consisting of 11 items measuring the difficulty in performing physical activities relevant to shoulder, arm or hand function. Each item is scored on a scale of 1-5 and a final score of 0 to 100 is calculated, with higher scores representing greater degrees of upper extremity disability (0 points indicate no disability and 100 points indicates maximum disability). For the primary analysis, change in QuickDASH score will be tracked across the first five occasions of assessment (i.e. baseline - 1 month) and the patient-level average trend will be compared between randomized groups. As a secondary analysis, change in QuickDASH will be tracked over the full duration of follow-up, with the primary focus being on outcomes up to 1 year. |
Change from baseline to 1 week, 2 weeks, 3 weeks, 1 month, 6 weeks, 3 months, 6 months, 12 months, and 24 months post CTR procedure were assessed. Change from baseline to 1 month, 1 year and 2 years were reported.
|
|
Measure the Effect of USCTR vs mOCTR on the Longitudinal Change in BCTQ-SSS.
Prazo: Change from baseline to 1 week, 2 weeks, 3 weeks, 1 month, 6 weeks, 3 months, 6 months, 12 months, and 24 months post CTR procedure were assessed. Change from baseline to 1 month, 1 year and 2 years were reported.
|
The BCTQ is a PROM for CTS and is the most commonly used outcome measure for CTS. Each item on the 11-item symptom severity scale (BCTQ-SSS) is graded from 1 (mildest) to 5 (most severe). Outcomes are typically recorded as a mean score. For the primary analysis, change in BCTQ-SSS score will be tracked across the first five occasions of assessment (i.e. baseline - 1 month) and the patient-level average trend will be compared between randomized groups. As a secondary analysis, change in BCTQ-SSS will be tracked over the full duration of follow-up, with the primary focus being on outcomes up to 1 year. |
Change from baseline to 1 week, 2 weeks, 3 weeks, 1 month, 6 weeks, 3 months, 6 months, 12 months, and 24 months post CTR procedure were assessed. Change from baseline to 1 month, 1 year and 2 years were reported.
|
|
Measure the Effect of USCTR vs mOCTR on the Longitudinal Change in Hand Grip Strength.
Prazo: Change from baseline to 3 months, and 12 months post CTR procedure. Mean grip strength at baseline, 3 months and 12 months were reported.
|
Manually tested using a handheld dynamometer. Between the mOCTR and USCTR groups, will compare hand grip strength across each time point (i.e. baseline - 3 months; baseline - 12 months). |
Change from baseline to 3 months, and 12 months post CTR procedure. Mean grip strength at baseline, 3 months and 12 months were reported.
|
|
Measure the Effect of USCTR vs mOCTR on the Longitudinal Change in Pinch (Tip, Palmar, and Key) Strength.
Prazo: Change from baseline to 3 months, and 12 months post CTR procedure. Mean pinch (tip, palmar, and key) strength at baseline, 3 months and 12 months were reported.
|
Manually tested using a pinch gauge. Between the mOCTR and USCTR groups, will compare pinch (tip, palmar, and key) strength across each time point (i.e. baseline - 3 months; baseline - 12 months). |
Change from baseline to 3 months, and 12 months post CTR procedure. Mean pinch (tip, palmar, and key) strength at baseline, 3 months and 12 months were reported.
|
|
Measure the Impact of USCTR vs mOCTR on Participant Perception of Change in Overall Physical Condition
Prazo: Captured at 1 week, 2 weeks, 3 weeks, 1 month, 6 weeks, 3 months, 6 months, 12 months, and 24 months post CTR procedure were assessed. % of participants that reported a GROC score of ≥ 5/7 at 1 month, 1 year, and 2 years were reported.
|
Participant self reported change in physical condition. Participant will select one response from the following descriptions to rate overall condition from the time they began treatment to the designated time-point: A very great deal worse; About the same; A very great deal better; A great deal worse; A great deal better; Quite a bit worse; Quite a bit better; Moderately worse; Moderately better; Somewhat worse; Somewhat better; A little bit worse; A little bit better; A tiny bit worse(almost the same); A tiny bit better (almost the same) The Global Rate of Change Scale (GROC) will be captured at 1 week, 2 weeks, 3 weeks, 1 month, 6 weeks, 3 months, 6 months, 12 months, and 24 months post-CTR. The primary focus will be on outcomes up to 1 year. |
Captured at 1 week, 2 weeks, 3 weeks, 1 month, 6 weeks, 3 months, 6 months, 12 months, and 24 months post CTR procedure were assessed. % of participants that reported a GROC score of ≥ 5/7 at 1 month, 1 year, and 2 years were reported.
|
|
Change in Military Work Status as Assessed Using Single-item Self-report Assessment
Prazo: Captured at 1 week, 2 weeks, 3 weeks, 1 month, 6 weeks, 3 months, 6 months, 12 months, and 24 months post CTR procedure. Status at 1 month, 1 year and 2 years were reported.
|
Participants will complete a questionnaire to depict when normal work or daily activities commenced. The primary focus will be on outcomes up to 1 year. |
Captured at 1 week, 2 weeks, 3 weeks, 1 month, 6 weeks, 3 months, 6 months, 12 months, and 24 months post CTR procedure. Status at 1 month, 1 year and 2 years were reported.
|
|
Surgical Time During Procedure (Minutes)
Prazo: Recorded at end of procedure (Baseline)
|
On the day the participant receives their study assigned procedure (USCTR vs. mOCTR), clinical team will record surgical time to perform the procedure in minutes. Surgical time was defined as the time from initial cut to incision closure. |
Recorded at end of procedure (Baseline)
|
|
Change in Self-reported Satisfaction as Assessed Using a Satisfaction Rating Scale
Prazo: Captured at 1 week, 2 weeks, 3 weeks, 1 month, 6 weeks, 3 months, 6 months, 12 months, and 24 months post CTR procedure. % of participants that reported a score of ≥ 5/7 at 1 month, 1 year and 2 years were reported.
|
Participants will rate satisfaction with the following: completely dissatisfied, mostly dissatisfied, somewhat satisfied, neither satisfied or dissatisfied, somewhat satisfied, mostly satisfied, or completely satisfied. Completely dissatisfied with represent the lowest score, and completely satisfied will represent the highest score. Will compare participant satisfaction across arms in terms of symptom improvement, incision appearance, and recovery, with the primary focus being on outcomes up to 1 year. |
Captured at 1 week, 2 weeks, 3 weeks, 1 month, 6 weeks, 3 months, 6 months, 12 months, and 24 months post CTR procedure. % of participants that reported a score of ≥ 5/7 at 1 month, 1 year and 2 years were reported.
|
|
Change in Self-reported Pain as Assessed Using the 11-item Numeric Pain Rating Scale (NPRS) Participant Pain Levels Over 1 Month Following the CTR Procedure.
Prazo: Captured at 1 week, 2 weeks, 3 weeks, and 1 month post CTR procedure. Change from baseline to 1 month was reported.
|
The 11-item NPRS scale is a unidimensional measure of pain intensity. It is a segmented numeric version of the visual analog scale in which participants will select a whole number (0-10 integers) that best reflects the intensity of their pain. The scale ranges from '0' representing one pain extreme (e.g. no pain) to '10' representing the other pain extreme (e.g. worst possible pain). |
Captured at 1 week, 2 weeks, 3 weeks, and 1 month post CTR procedure. Change from baseline to 1 month was reported.
|
|
Change in Pain Medication Usage as Assessed Using Single-item Self-report Assessment
Prazo: Captured at 1 week, 2 weeks, 3 weeks, 1 month, 6 weeks, 3 months, 6 months, 12 months, and 24 months post CTR procedure. Mean opioid use frequency at baseline and 1 week were reported due to highest clinical relevance.
|
Participant self-reported pain medication usage. Pain medication use frequency was self-reported on a scale from 0-5. The following frequency of use options are as follows: 0 = No use, 1 = Less than once a week, 2 = Once a week, 3 = Several times a week, 4 = Daily, 5 = Multiple times per day. Participant self-reported pain medication usage (e.g., cumulative dosage, drug category, duration of use, etc.) will be captured at nine occasions of assessment: 1 week, 2 weeks, 3 weeks, 1 month, 6 weeks, 3 months, 6 months, 12 months, and 24 months post-CTR. The primary focus will be on outcomes up to 1 year. |
Captured at 1 week, 2 weeks, 3 weeks, 1 month, 6 weeks, 3 months, 6 months, 12 months, and 24 months post CTR procedure. Mean opioid use frequency at baseline and 1 week were reported due to highest clinical relevance.
|
|
Incision Length in mm
Prazo: Recorded at end of procedure (Baseline)
|
On the day the participant receives their study assigned procedure (USCTR vs. mOCTR), clinical team will record incision length in mm |
Recorded at end of procedure (Baseline)
|
|
Change in Self-reported Pain as Assessed Using the 11-item Numeric Pain Rating Scale (NPRS)
Prazo: Pre-procedure (Baseline) and Immediately post-procedure. Mean immediate post-procedure pain scores were reported.
|
Using the 11-item Numeric Pain Rating Scale (NPRS), compare the distributions of participant self-reported pain at both pre- and immediately -post CTR procedure between the USCTR and mOCTR groups. The 11-item NPRS scale is a unidimensional measure of pain intensity. It is a segmented numeric version of the visual analog scale in which participants will select a whole number (0-10 integers) that best reflects the intensity of their pain. The scale ranges from '0' representing one pain extreme (e.g. no pain) to '10' representing the other pain extreme (e.g. worst possible pain). |
Pre-procedure (Baseline) and Immediately post-procedure. Mean immediate post-procedure pain scores were reported.
|
|
Change in Self-reported Pain as Assessed Using the Modified 2-item CTS Palmar Pain Scale (4 Items) Over 1 Month Following CTR Procedure
Prazo: Captured at 1 week, 2 weeks, 3 weeks, and 1 month post CTR procedure. Mean incisional pain score was reported at 4 weeks and mean incisional pain impact on function score was reported at 3 weeks due to highest clinical relevance.
|
The Modified 2-item CTS Palmar Pain Scale allows participants to report on their palmar (including pillar pain) and incisional pain and their impact on function separately, with higher scores indicating more pain and functional interference. The amount of palmar and incisional pain was assessed on a scale from 0 (No pain) to 6 (Very severe) and the impact of palmar and incisional pain on function was assessed on a scale from 0 (Not at all) to 5 (Extremely). |
Captured at 1 week, 2 weeks, 3 weeks, and 1 month post CTR procedure. Mean incisional pain score was reported at 4 weeks and mean incisional pain impact on function score was reported at 3 weeks due to highest clinical relevance.
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Matthew Miller, MD, Walter Reed National Military Medical Center
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- WRNMMC-2020-0278
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
produto fabricado e exportado dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .